Ascendis Health (JSE:ASC) Interest Expense : R-45 Mil (TTM As of Jun. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Ascendis Health's interest expense for the six months ended in Jun. 2023 was R 4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was R-45 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Ascendis Health's Operating Income for the six months ended in Jun. 2023 was R -76 Mil. Ascendis Health's Interest Expense for the six months ended in Jun. 2023 was R 4 Mil. Ascendis Health did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ascendis Health Interest Expense Historical Data

The historical data trend for Ascendis Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Health Interest Expense Chart

Ascendis Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

Get a 7-Day Free Trial

-397.08

-753.95

-1,037.91

-436.59

-45.26

Ascendis Health Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Interest Expense	Get a 7-Day Free Trial															-553.50	-397.58	-39.02	-49.43	4.16

Ascendis Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was R-45 Mil.

Ascendis Health (JSE:ASC) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ascendis Health's Interest Expense for the six months ended in Jun. 2023 was R4 Mil. Its Operating Income for the six months ended in Jun. 2023 was R-76 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was R19 Mil.

Ascendis Health's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

The higher the ratio, the stronger the company's financial strength is.

Ascendis Health (JSE:ASC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090

Website

https://www.ascendishealth.com

Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.